November 19, 2026 12:11 PM

printer

Health Ministry proposes separate licensing framework for wholesale of bulk drugs

The Ministry of Health and Family Welfare has proposed a separate licensing framework for wholesale of bulk drugs. The proposed amendments will introduce a separate application form (Form 19-BC) and licence form (Form 20-BC) for the sale of bulk drugs (active or inactive bulk substances) to the Drugs Rules, 1945.
 
Currently, a common licence covers the wholesale sale of both formulations and bulk drugs. The Ministry has said that the proposed amendment seeks to establish a dedicated licensing framework for bulk drugs, enabling more focused regulatory oversight of their wholesale sale and greater accountability in the pharmaceutical supply chain.
 
The proposal was agreed upon by the Drugs Consultative Committee in its 67th meeting held on Tuesday, and by the Drugs Technical Advisory Board in its 93rd meeting held in February this year. Under the proposed framework, the licence will capture the categories of bulk drugs handled by wholesalers, including drugs covered under the Narcotic Drugs and Psychotropic Substances Act, 1985. The sale of bulk drugs will be carried out under the personal supervision of a competent person, thereby strengthening accountability in their distribution and handling. 
 
Upon implementation, the proposed amendment will give better control over the sale of bulk drugs by way of wholesale, strengthen enforcement control in relation to antimicrobial resistance and the movement of NDPS drugs and require wholesalers of bulk drugs to obtain a separate licence for sale.
 
The Ministry has said that existing licensees will be provided adequate time to comply with the new provisions to facilitate the transition to the revised licensing requirements. The requirements will become applicable to them upon expiry of their current retention period or 12 months after the final publication of the amendment, whichever is later.
 
Stakeholders and members of the public are invited to submit their objections and suggestions, if any, to the Under Secretary (Drugs), Ministry of Health and Family Welfare, or via email at drugsdiv-mohfw@gov.in, within 30 days from the date on which copies of the Gazette containing the draft rules are made available to the public.